We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Stool DNA Extraction Kit for Molecular Diagnostics Faster, Simpler

By LabMedica International staff writers
Posted on 16 Aug 2011
A DNA extraction kit provides a faster, simpler method to purify genomic DNA from stool samples prior to PCR amplification and analysis.

The E-Sphere stool DNA extraction kit answers the market need for speed with the added benefits of accuracy, improved cost effectiveness, reduced risk of sample contamination, and greater safety for lab technicians. More...
The process requires only standard clinical laboratory equipment.

Advanced technology in the kit includes the high performance E-Sphere stool enzyme, a thermostable reagent that digests fecal matter at 75 °C during the 15-minute incubation stage. A further innovation is the proprietary E-Sphere clean-up column, which purifies the DNA.

Phthisis Diagnostics (Charlottesville, VA, USA) introduced the kit at the American Society for Microbiology annual meeting, which took place during May 21-24, 2011, in New Orleans (LA, USA). The kit allows lab workers to extract DNA from human stool samples in a three-step process. Other similar kits take three times the steps, said company cofounder and president Crystal Icenhour.

The E-Sphere stool sample-preparation method allows manual DNA extraction from 12 stool samples in less than 30 minutes. The process includes only nine steps and minimizes sample contamination risk with just 2 sample transfers. Stool samples can be quickly processed within a biological safety cabinet.

The kit was developed and manufactured in the USA to International Organization for Standardization (ISO) 9001 & ISO 13485 standards in a Quality Systems Registrars (QSR) & current Good Manufacturing Practice (cGMP) compliant facility, and is designated as a general-purpose reagent.

Related Links:

Phthisis Diagnostics


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Glucose Tolerance Test
NERL Trutol
New
cDNA Synthesis Kit
Ultimate cDNA Synthesis Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.